Drug · DIN 02524643
SOHONOS
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 20, 2022; first marketed June 20, 2022.
- Drug Identification Number (DIN)
- 02524643
- Company (DIN owner)
- Ipsen Biopharmaceuticals Canada IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Palovarotene M09AX11
- Class
- Human
- Record last updated
- July 30, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PALOVAROTENE | 2.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 21, 2022: NOC 27451New Drug Submission (NDS)
Other DINs named SOHONOS
- DIN 02524627 · Marketed
- DIN 02524635 · Marketed
- DIN 02524651 · Marketed
- DIN 02524678 · Marketed